Cite
HARVARD Citation
Russell, N. et al. (2022). Treatment intensification with FLAG‐Ida may improve disease control in younger patients with secondary acute myeloid leukaemia: long‐term follow up of the MRC AML15 trial. British journal of haematology. pp. 1344-1347. [Online].